Improving the evidence base of Markov models used to estimate the costs of scaling up antiretroviral programmes in resource-limited settings

BACKGROUND: Despite concerns about affordability and sustainability, many models of the lifetime costs of antiretroviral therapy (ART) used in resource limited settings are based on data from small research cohorts, together with pragmatic assumptions about life-expectancy. This paper revisits these...

Descripción completa

Detalles Bibliográficos
Autores principales: Leisegang, Rory, Maartens, Gary, Hislop, Michael, Regensberg, Leon, Cleary, Susan
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895747/
https://www.ncbi.nlm.nih.gov/pubmed/20594369
http://dx.doi.org/10.1186/1472-6963-10-S1-S3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895747/
https://www.ncbi.nlm.nih.gov/pubmed/20594369
http://dx.doi.org/10.1186/1472-6963-10-S1-S3

Ejemplares similares